Systemic barriers are making Canada’s legal medical cannabis program prohibitive, causing patients to seek treatment in recreational and unregulated channels with no oversight from medical practitioners, a new survey says. That situation could be partly to blame for...
Matt Lamers
Matt Lamers's Latest Posts
Aphria’s record Canadian cannabis sales marred by weak EU revenue
Strong demand in Canada for Aphria’s recreational marijuana products failed to offset disappointing international revenue in the Leamington, Ontario-based company’s first fiscal quarter. The Canadian producer’s net revenue declined 4.5% from the March-May period to...
Aurora Cannabis exits Australia’s Cann Group after $28M impairment charge
Alberta-based Aurora Cannabis sold off its stake in Australian medical marijuana company Cann Group, but the Canadian producer says it still sees promise in the Australian market. "We continue to see growth potential in this important market and will maintain active...
Israel’s IM Cannabis applies for Nasdaq listing
IM Cannabis Corp, a multinational medical marijuana company headquartered in Israel, has applied to list its shares on the Nasdaq stock exchange.
New Zealand extends medical cannabis transition to avoid supply disruption
Medical cannabis suppliers in New Zealand have been given an extension on new product-assessment rules that were set to take effect this month. That development came to light in a Medicinal Cannabis Agency (MCA) communication sent to industry stakeholders after...
Australia approves record number of medical cannabis patients
Australia’s medical cannabis market continues to grow. In September, more than 6,000 patients were approved for medical marijuana treatment through the country’s Special Access Scheme (SAS) Category B pathway.
Aurora Cannabis execs saw raises, bonuses despite multibillion-dollar loss
Top Aurora Cannabis executives were rewarded with millions of dollars in bonuses and raises for the fiscal year ended June 30, the company disclosed, despite mass layoffs and a loss exceeding 3 billion Canadian dollars ($2.3 billion). The Alberta-based company...
Ontario cuts into cannabis store shortage by doubling authorizations
Ontario's cannabis store regulator has started issuing 10 Retail Store Authorizations (RSA) per week, double the previous pace of five new stores weekly. The Alcohol and Gaming Commission of Ontario said in a notice on its website that "... as...
Change afoot at Ontario Cannabis Store with new CEO, board members
The Ontario Cannabis Store has its second interim chief executive in the space of one year after the province’s exclusive marijuana wholesaler announced the sudden departure of CEO Cal Bricker on Monday
Aurora Cannabis, billionaire Nelson Peltz ‘have concluded their relationship’
Aurora Cannabis and billionaire investor Nelson Peltz “have concluded their relationship,” a spokeswoman for the Alberta, Canada-based company confirmed to Marijuana Business Daily. Peltz's resignation was announced in a news release Monday...
Mistakes by Canada’s largest cannabis companies offer insight into global expansion
If there is a lesson to be learned from the overseas misadventures of Canada’s large cannabis producers in recent years, it is this: Being first to a market is a waste of time and money if that market is still years (or decades) away from producing material revenue—more so if you’re unable or unwilling to bankroll losses in the meantime.
BC won’t compel private cannabis stores to carry Indigenous products
Participation in British Columbia’s upcoming Indigenous Shelf Space Program will be voluntary for the province’s privately owned cannabis stores, according to provincial regulators.













